Overview
Gloria Negri practices in Milan, Italy. Ms. Negri is rated as a Distinguished expert by MediFind in the treatment of Rubinstein-Taybi Syndrome. Her top areas of expertise are Rubinstein-Taybi Syndrome, PARC Syndrome, Otopalatodigital Syndrome Type 1, and Rothmund-Thomson Syndrome.
Her clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Rubinstein-Taybi Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Rubinstein-Taybi SyndromeMs. Negri isDistinguished. Learn about Rubinstein-Taybi Syndrome.
- Advanced
- PARC SyndromeMs. Negri isAdvanced. Learn about PARC Syndrome.
- Experienced
- AgranulocytosisMs. Negri isExperienced. Learn about Agranulocytosis.
- Delayed GrowthMs. Negri isExperienced. Learn about Delayed Growth.
- Infantile NeutropeniaMs. Negri isExperienced. Learn about Infantile Neutropenia.
- Otopalatodigital Syndrome Type 1Ms. Negri isExperienced. Learn about Otopalatodigital Syndrome Type 1.
- Rothmund-Thomson SyndromeMs. Negri isExperienced. Learn about Rothmund-Thomson Syndrome.